Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2004 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: CARBOCAINE

« Back to Dashboard
Carbocaine is a drug marketed by Eastman Kodak and Hospira and is included in two NDAs. It is available from one supplier.

The generic ingredient in CARBOCAINE is mepivacaine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mepivacaine hydrochloride profile page.

Summary for Tradename: CARBOCAINE

Suppliers: see list1

Pharmacology for Tradename: CARBOCAINE

Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia

Clinical Trials for: CARBOCAINE

Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis
Status: Completed Condition: Symptomatic Irreversible Pulpitis

Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients
Status: Terminated Condition: Renal Insufficiency, Chronic

Dosage of Mepivacaine in Ultrasound Axillary Block
Status: Completed Condition: Nerve Block; Neuromuscular Blockade; Anesthesia

Spinal Mepivicaine With Fentanyl for Outpatient Knee Arthroscopy
Status: Completed Condition: Knee Arthroscopy

Ropivacaine Versus Ropivacaine Plus Mepivacaine for Sciatic Block
Status: Completed Condition: Subgluteal Sciatic Block

Duration of Sciatic Nerve Block After Injection of Local Anesthetic In or Around the Nerve
Status: Completed Condition: Orthopedic Surgical Procedures; Postoperative Pain

The Anesthetic Efficacy of 3% Mepivacaine Plus 2% Lidocaine With 1:100,000 Epinephrine for Lower Jaw Dental Injections
Status: Completed Condition: Pain

Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery
Status: Completed Condition: Arthroscopic Knee Surgery

Distribution Circumferential Versus Non Circumferential of Mepivacaine in the Median and Ulnar Nerves
Status: Recruiting Condition: Anesthesia

Ultrasound Guided Supraclavicular Nerve Block
Status: Completed Condition: Local Anesthetic

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Eastman Kodak
levonordefrin; mepivacaine hydrochloride
INJECTABLE; INJECTION012125Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Eastman Kodak
mepivacaine hydrochloride
INJECTABLE; INJECTION012125Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
mepivacaine hydrochloride
INJECTABLE; INJECTION012250Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn